National HealthCare CorporationNHCNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +17.93% | +22.74% | +25.75% | +28.74% | +12.48% |
| Gross Profit Growth | +19.83% | +18.08% | +27.65% | +33.51% | +17.89% |
| EBITDA Growth | +190.41% | -59.07% | +22.57% | -1.66% | -4.80% |
| Operating Income Growth | +61.59% | +32.03% | +96.86% | +51.38% | +44.33% |
| Net Income Growth | +311.91% | -78.59% | +22.86% | -11.63% | -8.30% |
| EPS Growth | +308.82% | -79.03% | +22.22% | -12.07% | -8.99% |
| EPS Diluted Growth | +301.47% | -78.69% | +22.49% | -12.14% | -8.42% |
| Weighted Average Shares Growth | +0.73% | +0.75% | +0.57% | +0.46% | +0.47% |
| Weighted Average Shares Diluted Growth | +2.24% | +1.15% | +0.46% | +0.28% | -0.02% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -51.45% | -50.30% | +306.96% | +24.00% | +322.09% |
| Free Cash Flow Growth | -61.13% | -72.96% | +797.26% | +22.85% | +463.37% |
| Receivables Growth | +26.08% | +24.57% | +12.76% | +29.03% | +2.39% |
| Inventory Growth | +6.33% | +22.38% | +19.46% | +19.00% | +0.05% |
| Asset Growth | +21.90% | +16.30% | +17.37% | +16.61% | +0.60% |
| Book Value per Share Growth | +10.30% | +7.06% | +8.05% | +7.55% | +6.56% |
| Debt Growth | +127.90% | +129.97% | +136.68% | +117.77% | -44.67% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +7.85% | +178.06% | +9.83% | +7.17% | +4.22% |